SlideShare une entreprise Scribd logo
By: James Cooper
         Khoa Le
  Andrea Fuentes
Who is affected by the
disease?
 There is no general age for when this
  disease occurs as it can occur at any
  given time. However, it is more
  common between the ages of 21-30
  years old.
 It occurs almost equally in male and
  females, with males experiencing it
  slightly more.
 There is no particular type of race
  where this disease is more
  predominant in.
What is Leukoplakia?
   Patches on the tongue, in the
    mouth, or in the inside of the
    cheek that occur in response to
    long-term irritation.
Signs and Symptoms of
Leukoplakia
   A sign that Leukoplakia is occuring is the
    development of a white patch, that
    slowly appears over weeks to months.
   Symptoms of Leukoplakia are:
    painless, fuzzy white patches on the side
    of the tongue; these sores are thick and
    slightly raised which makes them
    difficult to scrape off, are usually white
    or gray and can sometimes be
    red, which are called
    erythroplakia, which is a condition that
    can lead to cancer
Effects and Treatments of
Leukoplakia
   Effects of Leukoplakia are: Tobacco smokers
    must avoid all tobacco products and alcohol
    intake should be reduced by those who
    drink alcohol. All in all, leukoplakia is
    relatively harmless.

   Not all cases of Leukoplakia need treatment
    but in some cases treatments for
    Leukoplakia include: Systemic medications
    like antiviral drugs such as, valacyclovir;
    and Topical medications which are solutions
    applied to the spot of the Leukoplakia such
    as, tretinoin.
When does Leukoplakia
occur?
 Leukoplakia occurs at any time
  during your life but studies have
  shown that its most likely to occur
  between the ages of 21-30 and at
  a mean age of 40.
 Leukoplakia mainly affects the
  mucus membranes of the
  mouth, which is thought to be
  caused by irritation.
Causes of Leukoplakia
   Leukoplakia is caused by tobacco
    use, and this includes both chewing
    and smoking. Although its not a
    proven cause, long term alcohol use
    and other chronic irritants can
    contribute to Leukoplakia.
Sources
 -Dugdale, D. C., Schwartz, S., & Zieve, D. (2011, July 20).
 Leukoplakia. PubMed Health. Retrieved February
 6, 2012, from
 http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002041/
 -Mishra, M., Mohanty, J., Sengupta, S., & Tripathy, S.
 (2005). Epidemiological and clinicopathological study of
 oral leukoplakia. IJDVL. Retrieved February 6, 2012, from
 http://www.ijdvl.com/article.asp?issn=0378-
 6323;year=2005;volume=71;issue=3;spage=161;epage=
 165;aulast=Mishra
 -Williams, Darren R. "Dental Health and Leukoplakia."
 WebMD. WebMD, 15 Mar. 2009. Web. 06 Feb. 2012.
 <http://www.webmd.com/oral-health/guide/dental-health-
 leukoplakia>.
 -Mayo Foundation for Medical Education and Research
 (2010, November 2). Leukoplakia.
 http://www.cnn.com/HEALTH/library/leukoplakia/DS00458
 .html. Retrieved February 7, 2012, from
 http://www.cnn.com/HEALTH/library/leukoplakia/DS00458.
 html
 -David C. Dugdale (2010, July 20). Leukoplakia. MedLine
 Plus. Retrieved February 7, 2012, from
 http://www.nlm.nih.gov/medlineplus/ency/article/001046.
 htm

Contenu connexe

Tendances

Tendances (20)

mucocele
mucocelemucocele
mucocele
 
Pyogenic Granuloma
Pyogenic GranulomaPyogenic Granuloma
Pyogenic Granuloma
 
Ameloblastoma
AmeloblastomaAmeloblastoma
Ameloblastoma
 
Oral manifestations of hiv/ aids
Oral manifestations of hiv/ aidsOral manifestations of hiv/ aids
Oral manifestations of hiv/ aids
 
Oral precancerous lesions
Oral precancerous lesionsOral precancerous lesions
Oral precancerous lesions
 
Leukoplakia
LeukoplakiaLeukoplakia
Leukoplakia
 
Tumor of oral cavity
Tumor of oral cavityTumor of oral cavity
Tumor of oral cavity
 
Mucocele and Renula
Mucocele and RenulaMucocele and Renula
Mucocele and Renula
 
Dentigerous cyst
Dentigerous cystDentigerous cyst
Dentigerous cyst
 
Erythroplakia
ErythroplakiaErythroplakia
Erythroplakia
 
ORAL VESICULOBULLOUS LESION
ORAL VESICULOBULLOUS LESIONORAL VESICULOBULLOUS LESION
ORAL VESICULOBULLOUS LESION
 
Fibro osseous lesions of jaw
Fibro osseous lesions of jawFibro osseous lesions of jaw
Fibro osseous lesions of jaw
 
Oral ulcers
Oral ulcersOral ulcers
Oral ulcers
 
Oral Submucous Fibrosis
Oral Submucous FibrosisOral Submucous Fibrosis
Oral Submucous Fibrosis
 
Pigmented lesions of oral cavity
Pigmented lesions of oral cavityPigmented lesions of oral cavity
Pigmented lesions of oral cavity
 
Premalignant lesions and conditions
Premalignant lesions and conditionsPremalignant lesions and conditions
Premalignant lesions and conditions
 
Leukoplakia
LeukoplakiaLeukoplakia
Leukoplakia
 
Disorders of maxillary sinus
Disorders of maxillary sinusDisorders of maxillary sinus
Disorders of maxillary sinus
 
ORAL SUBMUCOUS FIBROSIS (OSMF)
ORAL SUBMUCOUS FIBROSIS (OSMF)ORAL SUBMUCOUS FIBROSIS (OSMF)
ORAL SUBMUCOUS FIBROSIS (OSMF)
 
Leukoplakia vs lichen planus.
Leukoplakia vs lichen planus.Leukoplakia vs lichen planus.
Leukoplakia vs lichen planus.
 

Similaire à Leukoplakia

4 keratoses and related disorders of oral mucosa ii
4  keratoses and related disorders of oral mucosa ii4  keratoses and related disorders of oral mucosa ii
4 keratoses and related disorders of oral mucosa ii
Rmz Study
 
Oral manifestations
Oral manifestationsOral manifestations
Oral manifestations
Jinny Shaw
 
Management of opportunistic infections (o is)
Management of opportunistic infections (o is)Management of opportunistic infections (o is)
Management of opportunistic infections (o is)
anasabkry
 

Similaire à Leukoplakia (20)

Leukoplakia
LeukoplakiaLeukoplakia
Leukoplakia
 
leukoplakia-190322142633.pdf
leukoplakia-190322142633.pdfleukoplakia-190322142633.pdf
leukoplakia-190322142633.pdf
 
4 keratoses and related disorders of oral mucosa ii
4  keratoses and related disorders of oral mucosa ii4  keratoses and related disorders of oral mucosa ii
4 keratoses and related disorders of oral mucosa ii
 
Leukoplakia
LeukoplakiaLeukoplakia
Leukoplakia
 
leukoplakia.pptx
leukoplakia.pptxleukoplakia.pptx
leukoplakia.pptx
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Leukoplakia
LeukoplakiaLeukoplakia
Leukoplakia
 
Oral manifestations
Oral manifestationsOral manifestations
Oral manifestations
 
Oral manifestation of leukemia
Oral manifestation of leukemiaOral manifestation of leukemia
Oral manifestation of leukemia
 
Leukoplakia case presentation
Leukoplakia case presentationLeukoplakia case presentation
Leukoplakia case presentation
 
Leukoplakia
LeukoplakiaLeukoplakia
Leukoplakia
 
uveitis Denis kamara.pptx
uveitis Denis kamara.pptxuveitis Denis kamara.pptx
uveitis Denis kamara.pptx
 
Premalignant lesion
Premalignant lesionPremalignant lesion
Premalignant lesion
 
Lichen planus
Lichen planusLichen planus
Lichen planus
 
Management of opportunistic infections (o is)
Management of opportunistic infections (o is)Management of opportunistic infections (o is)
Management of opportunistic infections (o is)
 
SLE ( Systemic lupus erythema)
SLE ( Systemic lupus erythema)SLE ( Systemic lupus erythema)
SLE ( Systemic lupus erythema)
 
Chapter 12 Opthalmology.pptx information
Chapter 12 Opthalmology.pptx informationChapter 12 Opthalmology.pptx information
Chapter 12 Opthalmology.pptx information
 
13 premalignant conditions_of_oral_cavity
13 premalignant conditions_of_oral_cavity13 premalignant conditions_of_oral_cavity
13 premalignant conditions_of_oral_cavity
 
Poliomyelitis (2015)
Poliomyelitis (2015)Poliomyelitis (2015)
Poliomyelitis (2015)
 
B03207012
B03207012B03207012
B03207012
 

Dernier

Dernier (20)

Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 

Leukoplakia

  • 1. By: James Cooper Khoa Le Andrea Fuentes
  • 2. Who is affected by the disease?  There is no general age for when this disease occurs as it can occur at any given time. However, it is more common between the ages of 21-30 years old.  It occurs almost equally in male and females, with males experiencing it slightly more.  There is no particular type of race where this disease is more predominant in.
  • 3. What is Leukoplakia?  Patches on the tongue, in the mouth, or in the inside of the cheek that occur in response to long-term irritation.
  • 4. Signs and Symptoms of Leukoplakia  A sign that Leukoplakia is occuring is the development of a white patch, that slowly appears over weeks to months.  Symptoms of Leukoplakia are: painless, fuzzy white patches on the side of the tongue; these sores are thick and slightly raised which makes them difficult to scrape off, are usually white or gray and can sometimes be red, which are called erythroplakia, which is a condition that can lead to cancer
  • 5. Effects and Treatments of Leukoplakia  Effects of Leukoplakia are: Tobacco smokers must avoid all tobacco products and alcohol intake should be reduced by those who drink alcohol. All in all, leukoplakia is relatively harmless.  Not all cases of Leukoplakia need treatment but in some cases treatments for Leukoplakia include: Systemic medications like antiviral drugs such as, valacyclovir; and Topical medications which are solutions applied to the spot of the Leukoplakia such as, tretinoin.
  • 6. When does Leukoplakia occur?  Leukoplakia occurs at any time during your life but studies have shown that its most likely to occur between the ages of 21-30 and at a mean age of 40.  Leukoplakia mainly affects the mucus membranes of the mouth, which is thought to be caused by irritation.
  • 7. Causes of Leukoplakia  Leukoplakia is caused by tobacco use, and this includes both chewing and smoking. Although its not a proven cause, long term alcohol use and other chronic irritants can contribute to Leukoplakia.
  • 8. Sources -Dugdale, D. C., Schwartz, S., & Zieve, D. (2011, July 20). Leukoplakia. PubMed Health. Retrieved February 6, 2012, from http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002041/ -Mishra, M., Mohanty, J., Sengupta, S., & Tripathy, S. (2005). Epidemiological and clinicopathological study of oral leukoplakia. IJDVL. Retrieved February 6, 2012, from http://www.ijdvl.com/article.asp?issn=0378- 6323;year=2005;volume=71;issue=3;spage=161;epage= 165;aulast=Mishra -Williams, Darren R. "Dental Health and Leukoplakia." WebMD. WebMD, 15 Mar. 2009. Web. 06 Feb. 2012. <http://www.webmd.com/oral-health/guide/dental-health- leukoplakia>. -Mayo Foundation for Medical Education and Research (2010, November 2). Leukoplakia. http://www.cnn.com/HEALTH/library/leukoplakia/DS00458 .html. Retrieved February 7, 2012, from http://www.cnn.com/HEALTH/library/leukoplakia/DS00458. html -David C. Dugdale (2010, July 20). Leukoplakia. MedLine Plus. Retrieved February 7, 2012, from http://www.nlm.nih.gov/medlineplus/ency/article/001046. htm